Wesfarmers’ new health division delivers $2.78b revenue

But PBS changes, increased competition, inflation and reduced COVID-19 anti-viral demand have a negative future impact Wesfarmers’ health division, built on the back of last year’s acquisition of Australian Pharmaceutical Industries (API) and its Priceline retail pharmacy banner, has reported $2.78 billion in revenue and just $27 million in earnings before interest and taxes (EBIT).